SpringWorks Therapeutics News

Express News | SpringWorks Therapeutics Inc : JP Morgan Cuts Target Price to $64 From $77

ReutersJun 11 23:59 ET

GSK, SpringWorks End Collaboration Agreement

Seeking AlphaJun 8 08:28 ET

Express News | SpringWorks Therapeutics Inc Says Termination Of License Deal Does Not Trigger Any Payment Obligations On Part Of Co/any Other Material Wind-Down Costs

BenzingaJun 7 16:27 ET

Express News | SpringWorks Therapeutics Says Termination Does Not Affect Co's Rights To Continue Developing Or Commercializing Its Products Or Product Candidates; Expects That GSK Will Continue Ongoing Clinical Trials Under License Agreement

BenzingaJun 7 16:26 ET

Express News | SpringWorks Therapeutics Inc - Termination of License Deal Does Not Trigger Any Payment Obligations on Part of Co/Any Other Material Wind-Down Costs

ReutersJun 7 16:25 ET

Express News | SpringWorks Therapeutics Inc - Co Expects That GSK Will Continue Ongoing Clinical Trials Under License Agreement

ReutersJun 7 16:25 ET

Express News | SpringWorks Therapeutics Inc - Termination Does Not Affect Co's Rights to Continue Developing or Commercializing Its Products or Product Candidates

ReutersJun 7 16:25 ET

Express News | SpringWorks Therapeutics:Deal Termination Between Co & Glaxosmithkline Intellectual Property Development Effective 180 Days After Notice Receipt

ReutersJun 7 16:24 ET

Express News | SpringWorks Therapeutics:Got Notice of Termination of Amended & Restated Collaboration and License Agreement, Dated Sept 6, 2022, Between Co & GSK

ReutersJun 7 16:22 ET

Insider Sale: Director Julie Hambleton Sells Shares of SpringWorks Therapeutics Inc (SWTX)

Yahoo FinanceJun 6 02:34 ET

SpringWorks Therapeutics(SWTX.US) Officer Sells US$801.37K in Common Stock

$SpringWorks Therapeutics(SWTX.US)$ Officer Edris Badreddin sold 20,000 shares of common stock on Jun 3, 2024 at an average price of $40.0686 for a total value of $801.37K.Source: Announcement What is

moomoo NewsJun 5 16:52 ET

SpringWorks Therapeutics(SWTX.US) Director Sells US$186.05K in Common Stock

$SpringWorks Therapeutics(SWTX.US)$ Director Hambleton Julie sold 4,648 shares of common stock on Jun 3, 2024 at an average price of $40.0275 for a total value of $186.05K.Source: Announcement What is

moomoo NewsJun 5 16:52 ET

Springworks Therapeutics Insider Sold Shares Worth $801,372, According to a Recent SEC Filing

Badreddin Edris, Chief Operating Officer, on June 03, 2024, sold 20,000 shares in Springworks Therapeutics (SWTX) for $801,372. Following the Form 4 filing with the SEC, Edris has control over a total

MT NewswiresJun 5 16:13 ET

SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

STAMFORD, Conn., June 05, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (NASDAQ:SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced that management

GlobeNewswireJun 5 07:00 ET

Barclays Maintains SpringWorks Therapeutics(SWTX.US) With Buy Rating, Maintains Target Price $63

Barclays analyst Peter Lawson maintains $SpringWorks Therapeutics(SWTX.US)$ with a buy rating, and maintains the target price at $63.According to TipRanks data, the analyst has a success rate of 41.8%

moomoo NewsJun 5 04:31 ET

Form 144 | SpringWorks Therapeutics(SWTX.US) Officer Proposes to Sell 2.07 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Jun 3, $SpringWorks Therapeutics(SWTX.US)$ Officer Badreddin Edris intends to sell 50,000 shares of its common stock on Jun 3, with a total market value of approximately $2.07

moomoo NewsJun 3 16:44 ET

Form 144 | SpringWorks Therapeutics(SWTX.US) Insider Proposes to Sell 192.61K in Common Stocks

SEC FILLINGS DISCLOSED/ Jun 3, $SpringWorks Therapeutics(SWTX.US)$ Insider Julie Hambleton intends to sell 4,648 shares of its common stock on Jun 3, with a total market value of approximately $192.61

moomoo NewsJun 3 16:42 ET

Analysts Offer Insights on Healthcare Companies: Springworks Therapeutics (SWTX), Cyclo Therapeutics (CYTH) and Oncternal Therapeutics (ONCT)

TipRanksMay 31 06:30 ET

SpringWorks Therapeutics Announces Data to Be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

SpringWorks Therapeutics, Inc. (Nasdaq: SWTX) today announced that four abstracts from the company's portfolio will be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 31 to June 4, 2024.

GlobeNewswireMay 23 17:13 ET

Need To Know: Analysts Are Much More Bullish On SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Revenues

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's forecasts. The consensus estimated revenue n

Simply Wall StMay 11 08:57 ET